Oral Impact®

DIETARY_SUPPLEMENT3 trials

Sponsors

Rennes University Hospital, Prince of Songkla University, Fondazione Melanoma Onlus

Conditions

CirrhosisHepatocellular CarcinomaLiver CancerLiver FibrosisLocally Advanced MelanomaMelanoma MetastaticOral Mucositis

Phase 2

Effect of a Perioperative Oral Nutritional Supplementation on Patients Undergoing Hepatic Surgery for Liver Cancer

TerminatedNCT00151671

Rennes University HospitalCirrhosis, Hepatocellular Carcinoma, Liver Cancer +1

Start: 2003-04-30End: 2008-09-30Updated: 2012-02-27

Benefits of Immunonutrition in Patients With Head and Neck Cancer Receiving Chemoradiation

CompletedNCT05101889

Prince of Songkla UniversityOral Mucositis

Start: 2013-01-11End: 2017-01-31Updated: 2021-11-01

Unknown Phase

Study to Evaluate Impact® as Support to Anti PD1 or Anti PD1 Based Regimen Treatment in Patients With Inoperable Locally Advanced or Metastatic Melanoma

RecruitingNCT06880198

Fondazione Melanoma OnlusLocally Advanced Melanoma, Melanoma Metastatic

Start: 2024-08-01End: 2027-07-31Target: 20Updated: 2025-09-17

Related Papers

Benefits of immunonutrition in patients with head and neck cancer receiving chemoradiation: A phase II randomized, double-blind study.

2021-12-2817 citations